GlaxoSmithKline plc.

G S K House 980 Great West Road , Brentford, TW8 9GS

Public
Healthcare & Pharmaceuticals - Pharmaceuticals
over $1B
over 10K
+44.20.8047.500
(314) 621-3070
info@glaxosmithkline.com


We exist to improve the quality of human life by enabling people to do more, feel better, live longer. As one of the few healthcare companies researching both medicines and vaccines for the World Health Organization's three priority diseases HIV/AIDS, tuberculosis and malaria, we are very proud to have developed some of the leading global medicines in these fields. Our product portfolio also includes a range of consumer brands, many of which are household names around the world: Lucozade, Sensodyne, Aquafresh, Ribena, Horlicks, Panadol, Tums. ... (Source: SEC reports)


Competitor - 1/8
Which company is more competitive with GlaxoSmithKline plc.?




1272 Contacts at this company
Linda Henderson
Director, Clinical Development
Aimee Garriga
Senior Media Manager
Tracy Morrison
Compliance Consultant
Emily Miller
CPFR Analyst
Timothy Paul Simon
Vice President and Commercial Lead ...
Jeff Brunner
Global Design Director Respiratory Health ...
Larry Wolfe
Biological Safety Manager
Jim Ellis
Vice President, Head Boston Innovation Hub ...
Megan Papadopoulos
Deputy Director, Pulmonary Rare

Jul 21, 2017 21:37:22
LONDON, July 21, 2017 /PRNewswire/ -- GSK announced today that the US Food and Drug Administration (FDA) has approved a new subcutaneous formulation of Benlysta (belimumab) for the treatment of adult [...]

Jul 14, 2017 21:37:42
PHILADELPHIA, July 14, 2017 /PRNewswire/ -- GSK (LSE/NYSE: GSK) today announced it has begun shipping quadrivalent vaccine doses to US healthcare providers, following licensing and lot-release approval from [...]

Jun 21, 2017 21:37:43
LONDON, June 21, 2017 /PRNewswire/ -- GSK (LSE/NYSE: GSK) today will be presenting new results from a clinical study showing that its candidate vaccine for the prevention of [...]

May 1, 2017 20:07:04
ROCKVILLE, Md., May 1, 2017 /PRNewswire/ -- GSK today announced $139 million of new investment in its biopharmaceutical manufacturing site in Rockville, MD to support growing demand for BENLYSTA® (belimumab) for [...]

Apr 18, 2017 17:42:27
LOME, Togo--(BUSINESS WIRE)--GSK, Merck Sharp & Dohme (MSD), and the MECTIZAN® Donation Program (MDP) congratulate President Faure Gnassingbé, the  [...]

Get Started Today : Sign up in 20 seconds
Search with 20+ criteria.
Export results in seconds.
Bad emails?
No worry, we give two extras for every bad email.